# Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism

> **NCT02156427** · PHASE3 · COMPLETED · sponsor: **Laboratoires Genévrier** · enrollment: 38 (actual)

## Conditions studied

- Vitiligo
- Piebaldism

## Interventions

- **DEVICE:** VITICELL
- **DEVICE:** PLACEBO

## Key facts

- **NCT ID:** NCT02156427
- **Lead sponsor:** Laboratoires Genévrier
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04-29
- **Primary completion:** 2018-04-10
- **Final completion:** 2018-04-10
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02156427

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02156427, "Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02156427. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*